Nifty Next 50 64255.55 (0.72)
Nifty Pharma 21126.75 (1.21)
Nifty Smallcap 100 16410.2 (0.37)
SENSEX 78553.2 (1.96)
Nifty 50 23851.65 (1.77)
Nifty Bank 54290.2 (2.21)
Nifty IT 33372.35 (0.23)
Nifty Midcap 100 52657.8 (0.60)
NIKKEI 225 34734.85 (1.04)
HANG SENG 21395.14 (1.61)
S&P 5338.5 (0.26)
27-Apr-2024
Sales up 11%, net up 9%
'Consolidated net sales (including other operating income) of KSB for the quarter ended Mar 2024 has increased 11.15% to Rs 544.2 crore. Operating profit margin has declined from 11.68% to 11.19%, leading to 6.47% rise in operating profit to Rs 60.90 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 48.79% to 50.12%. Purchase of finished goods cost rose from 6.75% to 8.49%. Employee cost increased from 13.45% to 13.62%. Other expenses fell from 19.37% to 16.81%. Other income rose 12.90% to Rs 10.5 crore. PBIDT rose 7.37% to Rs 71.4 crore. Provision for interest rose 12.50% to Rs 0.9 crore. PBDT rose 7.31% to Rs 70.5 crore. Provision for depreciation rose 10.26% to Rs 12.9 crore. Profit before tax grew 6.67% to Rs 57.60 crore. Share of profit/loss was 75% higher at Rs 2.1 crore. Provision for tax was expense of Rs 15.1...
(18-Apr-2025)
Improving margins and market share
Revenue up 5% YoY to Rs 3729 crore in FY2025
Revenue up 8% YoY to Rs 40925 crore in Q4FY2025
(17-Apr-2025)
Net profit up 25.9% YoY to Rs 3569.6 crore in Q4FY2025
Analyst Meet / AGM-Conference Call (06-Mar-2025)
Order intake was higher in CY2024 compared to last year
Results-Analysis (28-Feb-2025)
Net up 33% largely on higher sales, higher OI and lower taxation
Results-Analysis (15-Nov-2024)
Sales up 9%, net up 23%
Results-Analysis (01-Aug-2024)
Sales up 9%, net up 8%